Ingrid Magean

Before joining Patton Boggs, Ms. Magean worked as a Research Associate and later as Project Manager for a pharmaceutical regulatory and strategic consulting firm.  She gained experience in supporting clients in drug development applications for generic and innovator drugs, medical devices, and biologics, as well as an in-depth familiarity with regulatory processes with FDA’s Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health. Previously, Ms. Magean was an intern for an international nonprofit organization in London, where she conducted independent research on issues concerning health and environmental quality in developing nations.